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THE ROLE OF HIF-1α IN INTESTINAL EPITHELIAL BARRIER FUNCTION  
IN ALCOHOLIC LIVER DISEASE 
 
Tuo Shao 
JULY 7, 2017  
 
Hypoxia inducible factor 1 α (HIF1α) is an oxygen-responsive subunit. 
HIF-1α plays a pivotal role in many pathophysiological processes. In addition to 
oxygen availability, HIF-1α can be regulated by multiple other factors in response 
to various pathophysiological processes. Previous studies showed that hepatic 
HIF-1α could be beneficial or harmful in experimental alcoholic liver disease 
(ALD). However, the role of intestinal HIF-1α in ALD has not yet been studied.  
Given the critical role of the gut-liver axis in ALD, it is important to elucidate the 
role of intestinal epithelial HIF-1α in ALD.  
        In the first chapter, we used wide type (WT) and intestinal epithelial-specific 
HIF-1α knockout (IEhif-1α-/-) mice to build chronic ALD model. Alcohol feeding 
significantly increased serum levels of ALT and LPS, hepatic triglyceride 
concentration, and liver injury in the IEhif-1α-/- mice compare with WT mice. 
Alcohol exposure resulted in greater reduction of the expression of intestinal 
	 v		
epithelial tight junction proteins and antimicrobial substance in IEhif-1α-/- mice. 
Bacterial analysis of the fecal samples showed an increased dysbiosis with a 
significantly decreased firmicutes/bacteroidetes ratio in IEhif-1α-/- mice compared 
to the WT mice exposed to alcohol.  
          In the second chapter, we used a more severe intestinal damage model- 
dextran sodium sulfate (DSS) induced colitis with binge ALD model in the same 
mice. DSS treatment alone did not affect liver function in both WT and IEhif-1α-/- 
mice. However, serum ALT, AST and LPS levels were significantly elevated in 
DSS + alcohol treatment groups, and these elevations were more pronounced in 
IEhif-1α-/- mice. DSS induced a marked increase in CRAMP expression in WT 
mice. However, this elevation was impaired in the IEhif-1α-/- mice. EtOH exposure 
eliminated the increased of CRAMP both in WT and IEhif-1α-/- mice. Therefore, 
we used global CAMP-/- mice to identify our hypothesis.  As we expected, binge 
alcohol on colitis enhance liver injury in CAMP-/- mice compared with WT mice.  
          In summary, our results demonstrate that intestinal HIF1α is required for 
the adaptation response to alcohol exposure-induced changes in intestinal 
microbiota and barrier function associated with elevated endotoxemia and 
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          Alcohol intake remains one of the most important cause of liver cirrhosis in 
the Western world. The causal association between alcohol intake and the 
development of ALD has been well demonstrated. Alcohol is commonly 
consumed worldwide and is associated with a spectrum of liver injury including 
simple steatosis or fatty liver, alcoholic hepatitis, fibrosis, and cirrhosis [1,2]. 
Hepatic steatosis is present in more than 90% of heavy drinkers, is reversible 
with abstinence. However, with continued alcohol intake, alcoholic hepatitis (AH) 
can be occurred. The prognosis of AH is variable, with nearly 100% survival in 
mild cases as compared to high short-term mortality among the most severe 
cases. With continued excessive alcohol consumption, patients are at risk for the 
development of fibrosis and cirrhosis. Twenty to 40% of patients with steatosis 
will develop to fibrosis, of which 8–20% will progress cirrhosis. As in other liver 
diseases, patients with cirrhosis are at risk for hepatocellular carcinoma (HCC) 
[3,4]. Despite the profound impact of ALD on public health, relatively few 
advances have been made in this field. The disease pathogenesis remains 
incompletely understood, and medical treatment for ALD has not changed 
significantly in 40 years.      
        Oxygen delivery to the liver and small intestine is significantly decreased 
following alcohol ingestion, while the oxygen extraction and consumption are 
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significantly enhanced in both organs [5,6]. Hypoxia plays a role in 
pathophysiological conditions such as inflammation, oxidative stress,  apoptosis, 
and dysregulated barrier function and innate immunity [7–9]. The hypoxia 
inducible transcription factors (HIFs) are key elements in the response to hypoxia 
in virtually all cells and tissues. HIF consists of an α subunit and a β subunit. 
Three α subunits,  termed HIF1 α, HIF2 α, and HIF3 α, have been described in 
humans, mice, and rats; all bind to a common β subunit named, alternatively, 
HIF1β, or the aryl-hydrocarbon-nuclear receptor translocator [ARNT] [10]. HIF-1, 
the major transcriptional factor activated during hypoxia, is known to regulate 
hypoxia-associated responses [11]. Under normoxic conditions, HIF-1α is rapidly 
degraded in a ubiquitin-dependent manner, whereas it escapes degradation 
under conditions of hypoxia. Accumulated HIF-1α dimerizes with HIF-1β, 
translocates to the nucleus, and regulates numerous gene transcription programs 
[8,9,12,13]. 
          HIF stabilization has been reported in acute and chronic alcoholics and in 
a murine model of ALD [14–20]. Alcohol-induced fatty liver shares similar clinical 
features and underlying pathogenesis with Non-alcoholic fatty liver disease 
(NAFLD). Therefore, it is likely that HIF-1α contributes to the development of 
hepatic steatosis in ALD as well as in NAFLD. However, the role of HIF-1α in the 
pathogenesis of ALD has not clear. To date, there are only six reports describing 
the involvement of HIF-1α in alcohol-associated hepatic steatosis, and some 
results are contradictory. 
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Hypoxia Inducible Factor 1α regulation: A Common Mechanism of Lipid 
Accumulation in ALD? 
          Multiple lines of evidence show that hypoxia and/or HIF may play a role in 
hepatic lipid accumulation. Two studies have implied a role for hypoxia in altering 
lipid storage in ALD, but their finding are contradictory [14,15]. Both studies used 
the HIF-1α f/f/AlbCre mice, in which HIF-1α is knockout conditionally in 
hepatocytes. The earlier study demonstrated that compared with WT mice, 
deficiency of HIF-1α produced less hepatic steatosis [15]. This study 
demonstrated that HIF-1α protein expression and its DNA-binding activity was 
increased by monocyte chemotactic protein (MCP)-1 which was an upstream 
activator. In contrast, the later study demonstrated that alcohol feeding increased 
hepatic steatosis and serum triglyceride concentration in hepatic HIF-1α KO mice 
[14]. The data showed that lipogenic genes, such as acyl-CoA carboxylase 
(ACC)-1, fatty acid synthase (FAS), and stearoyl-CoA desaturase (SCD)-1 were 
enhanced in HIF1α KO than in WT mice [14]. These lipogenic genes are 
regulated by sterol regulatory element-binding protein (SREBP)-1c, which is 
repressed by differentiated embryo chondrocyte 1 (DEC1). DEC1 is one of 
transcriptional targets of HIF-1α. The result demonstrated that DEC1 was 
increased in alcohol-fed WT but not HIF1α KO mice. Furthermore, prolyl 
hydroxylase (PHD) inhibitor dimethyloxaloylglycine (DMOG), were able to 
decrease steatosis in HIF-1α KO mice [14]. 
          The discrepant results obtained from the two studies may be due to 
differences in the experimental details, for example, intestinal microbiome 
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differences of animals, the different dose of ethanol, and the different control 
mice. Furthermore, these two studies only focused on determine the role of HIF 
in alcohol-induced steatosis, which is an early manifestation of ALD. The role of 
HIF signaling in other forms of ALD has not been studied. It is important to 
elucidate whether and how HIFs may play a role in the disease progression in 
future studies. 
 
Hepatic Hypoxia Inducible Factor 1α and Cytochrome P450 2E1 in ALD 
          Ethanol is metabolized to acetaldehyde by alcohol dehydrogenase (ADH), 
ethanol-inducible cytochrome P450 2E1 (CYP2E1), and catalase (CAT); 
acetaldehyde is further oxidized to acetate by mitochondrial aldehyde 
dehydrogenase (ALDH2) [21,22]. CYP2E1 potentiates ethanol-induced oxidative 
stress and fatty liver, and at high levels, plays a role in ethanol-induced liver 
damage as shown by experiments using CYP2E1 inhibitors [23,24]. CYP2E1 has 
been examined in ethanol-induced hypoxia in the liver [13].  Studies also showed 
that activation of HIF1α could either protect against or promote CYP2E1-
dependent toxicity.  
          The study by Wang, XD et al. demonstrated that CYP2E1 knock-in (KI) 
potentiates ethanol-induced oxidative stress, fatty liver and liver injury [13]. This 
study showed that protein levels of HIF1α and downstream targets of HIF-1α 
activation were elevated in the ethanol-fed CYP2E1 KI mice compared to the WT 
and CYP2E1 KO mice. Levels of HIF prolyl hydroxylase 2 were reduced in the 
ethanol-fed CYP2E1 KI mice, along with the increases in HIF-1α. In situ double 
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staining showed that pimonidazole and CYP2E1 were co-localized to the same 
area of injury in the hepatic centrilobular tissue. Increased protein levels of HIF-
1α were also found after acute ethanol treatment of the KI mice. Treatment of 
HepG2 E47 cells (which express CYP2E1) with ethanol plus arachidonic acid 
(AA) caused loss of cell viability to a greater extent than in HepG2 C34 cells, 
which do not express CYP2E1 [13]. These treatments elevated protein levels of 
HIF-1α to a greater extent in E47 cells than in C34 cells. The HIF-1α inhibitor (2-
Methoxyestradiol) also blocked the elevated oxidative stress produced by 
ethanol/AA in the E47 cells. These results suggest that blocking HIF-1α 
activation and actions may have therapeutic application for protection against 
ethanol/CYP2E1-induced hepatic oxidative stress, steatosis, and liver injury [13]. 
These regulatory mechanisms of CYP2E1 and HIF-1α in chronic ALD were also 
demonstrated in acute binge alcohol model [18]. The authors concluded that 
binge alcohol promotes acute hypoxic liver injury in mice and humans at least 
partly by activating the CYP2E1–HIF1α-dependent apoptosis pathway.  
Hepatic Hypoxia Inducible Factor 1α and MicroRNA-1222 in ALD 
          MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate 
post transcriptional gene expression via RNA silencing. MicroRNAs have been 
reported to control the liver tumor development and aggressiveness [25]. One of 
the most abundant miRNAs in the liver is miR-122. Decreases of miR-122 in liver 
tissue have been correlated with gain of metastatic properties of liver cancer and 
increased mortality [26]. Acute ethanol ingestion leads to a significant rise in miR-
122 [27]. Recent study shown that miR-122 regulates HIF-1α in hepatocytes in a 
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diet-induced steatohepatitis animal model [28]. More recently, it was 
demonstrated that alcoholic steatohepatitis accelerates hepatobiliary tumors by 
loss of miR-122 expression with a significant up-regulation of the miR-122 target, 
HIF-1α [20]. The study showed that chronic alcohol feeding in adult mice 
accelerated	 diethyl-nitrosamine (DEN) induced liver tumor development with 
molecular characteristics of HCC. Increased progenitor cell activation was 
triggered in the alcoholic liver tissue microenvironment and was characterized by 
high levels of pro-inflammatory signals of both innate (TNFα and MCP-1) and 
adaptive immunity, and activation of HIF-1α. 
 
Intestinal Hypoxia Inducible Factor 1α regulation: A Common Mechanism in 
Gut-Liver Axis in ALD? 
           The attenuation of alcohol-induced endotoxemia and liver damage by 
antibiotics indicates that endotoxin plays an important role in alcoholic liver 
damage [29]. Endotoxins are lipopolysaccharides (LPSs) derived from the cell 
walls of gram-negative bacteria. Both dead bacteria and the LPS shed from the 
cell walls contribute to the circulating endotoxins. Cellular targets of LPS in the 
liver include Kupffer cells, sinusoidal endothelial cells, stellate cells, neutrophils, 
and hepatocytes [30]. Normally, Kupffer cells in the liver detoxify endotoxins by 
phagocytosis. In Kupffer cells, lipopolysaccharide binding protein (LBP) presents 
LPS to CD14, a 55-kDa glycoprotein [31], and activates the MyD88-independent 
and dependent signaling pathway through TLR4. TLR4 activation results in the 
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production of proinflammatory cytokines such as tumor necrosis factor (TNF)-α 
and reactive oxygen species (ROS) that contribute to hepatocellular damage [32]. 
          Alcohol induced intestinal barrier dysfunction increases circulating 
endotoxin levels. Endotoxin absorption and leak is impeded by normal mucosal 
barrier function, and loss of normal barrier function may play an important role in 
causing endotoxemia in alcoholics. The intestines rely on an extensive 
underlying vasculature, and therefore are major targets for conditions of 
attenuated blood flow and result tissue hypoxia [33]. Both adaptive and 
proinflammatory responses have been attributed to conditions of hypoxia [34,35], 
and it is now clear that responses to hypoxia include transcriptionally regulated 
gene expression coordinated by HIF [36,37]. As important regulators of oxygen 
homeostasis, HIF-1α and HIF-2α have been implicated in transcriptional 
regulation of anti-inflammatory or tissue-protective-signaling pathways [38,39]. 
For example, a number of barrier-protective genes are critically regulated by HIF-
α, including intestinal trefoil factor (ITF), CD73, and multidrug resistance gene-1 
(MDR1). Among these, ITF, Muc3, defensins, CRAMP, Claudin-1 and CD73 
appear to serve as barrier-protective factors during hypoxia in vivo. There are 
also a number of factors other than hypoxia, such as lipopolysaccharide (LPS) 
that regulate HIF-1 expression and accumulation. A recent study demonstrates 
that long time exposure to LPS impairs HIF-1α induction that, in turn, reduces the 
ability of cells to survive and function under hypoxia conditions [40]. 
          A recent study in our lab showed that chronic alcohol feeding decreased 
HIF-2α protein levels in the intestines of mice [41]. However, the role of intestinal 
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HIF1α has not been studied in ALD. We proposed that HIF-1α plays a critical role 
in the intestine by regulating gut microbiota homeostasis and barrier function in 
ALD. HIF-1α upregulation in the intestine serves as a compensatory mechanism 
to increase factors that reduce gut dysbiosis leading to reduced LPS production 
and enhanced barrier function that inhibits the translocation of bacteria and their 
products in ALD. We expect that deficiency of intestinal HIF-1α exacerbates gut 
dysbiosis, intestinal barrier dysfunction, increased LPS and bacterial 
translocation into the liver, and eventually, liver damage. We also expect that 
upregulation of HIF-1α by intestinal pathogenesis, such as inflammatory bowel 
disease, provides a feed-back mechanism to limit the intestinal barrier 
dysfunction, and deficiency of intestinal HIF-1α leads to further exacerbation of 














INTESTINAL HIF-1α DELETION EXACERBATES ALCOHOLIC  





           Alcoholic liver disease (ALD) ranges from hepatic steatosis to 
steatohepatitis, cirrhosis, and, potentially, hepatocellular carcinoma [1]. While 
alcohol induces deleterious effects in the liver, it also disrupts the gut microbiota 
homeostasis and intestinal epithelial integrity resulting in an increased 
permeability, bacterial translocation and release of bacteria-derived endotoxin 
into the circulation [2-4]. Clinical and experimental studies have demonstrated 
that serum levels of lipopolysaccharide (LPS) are, indeed, increased in alcoholic 
subjects [5, 6]. LPS binding to Toll-like receptors (TLRs) on the surface of Kupffer 
cells leads to an elevated pro-inflammatory cytokine production, which, in turn, 
damages hepatocyte function [7, 8].  
          Intestinal barrier function is key to preventing the increased bacterial 
translocation by alcohol [6, 9, 10]. Goblet cells in the intestinal epithelium 
produce protective trefoil factors and mucins, which are abundantly core 
glycosylated and either localized to the cell membrane or secreted into the lumen 
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to form the mucus layer [11, 12]. The mucus is the first barrier that intestinal 
bacteria meet, and pathogens must penetrate it to reach the epithelial cells [13, 
14]. Additionally, trefoil factors stimulate expression and secretion of mucins and 
play a role in building/modifying the mucus layer and promoting epithelial tight 
junction integrity [15]. Intestinal Paneth cells produce antimicrobial peptides that 
are retained in the mucus layer, thereby concentrating their bactericidal activity 
close to the epithelium. Together, Paneth and Goblet cells prevent bacterial 
invasion to some extent, and thereby play a prominent role in the innate immune 
surveillance of the gut [12]. A single layer of epithelial cells forms the main 
physical barrier between the lumen and mucosal tissues. The paracellular space 
is sealed by tight junctions (TJ), which regulate the flow of small molecules 
through the composition of claudins and other proteins in the junctional complex 
[16]. IgA production and other intestinal immune-regulators provide protection 
against bacterial transcytosis [17]. Recent studies demonstrate that targeting 
intestinal barrier function may be an effective strategy in the prevention/treatment 
of ALD [18].  
          The intestines are supported by an extensive underlying vasculature, and 
are therefore susceptible to conditions related diminished blood flow and 
concomitant tissue hypoxia [19, 20]. It is now clear that the responses to hypoxia 
include transcriptionally regulated gene expression coordinated by the 
transcription factor hypoxia-inducible factor (HIF) [21]. HIF-1α and HIF-2α have 
been implicated in transcriptional regulation of anti-inflammatory or tissue-
protective-signaling pathways [22-24]. A number of barrier-protective genes are 
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critically regulated by HIF-1α, including intestinal trefoil factor (ITF), CD73, P-
glycoprotein (P-gp), cathelicidin, claudin-1, muc3 and β-defensin-1(DEFB1) [19, 
25-30]. While hypoxia is an important factor for HIF-1α protein stabilization, there 
are also a number of factors other than hypoxia, such as LPS, that regulate HIF-
1α expression and accumulation [31]. A recent study demonstrates that long time 
exposure to LPS impairs HIF-1α induction, which then reduces cell viability and 
function under hypoxia conditions [32].  
          Disruption of epithelial HIF-1α resulted in an increased epithelial 
permeability, as shown in murine colitis models [33-36]. Our previous study 
showed that long-term exposure to alcohol decreased epithelial HIF-2α protein 
expression in mice [37]. We also demonstrated that knockdown of HIF1/2α 
resulted in an increased permeability and a decreased trans-epithelial electrical 
resistance (TEER) in Caco-2 cells [37, 38]. However, it is unknown whether 
intestinal epithelial HIF-1α is critical in maintaining intestinal barrier function in 
response to alcohol exposure in mice.  
          In the present study, we discovered that intestinal epithelial specific HIF-1α 
knockout (IEhif1α-/-) worsens alcohol-induced liver injury. We showed that alcohol 
exposure in IEhif1α-/- mice resulted in a more severe dysbiosis, bacterial 
translocation and liver injury. IEhif1α-/- mice had decreased levels of antimicrobial 
peptide in the intestine and an increased intestinal inflammation. Probiotic 
administration decreased alcohol-induced liver injury in wild type (WT) mice but 
not in IEhif1α-/- mice. Sterilizing the gut using non-absorbable antibiotics 
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attenuated liver-injury in IEhif1α-/- mice. Our results suggest that targeting 
intestinal HIF-1α may be a strategy for preventing ALD.     
 
 
MATERIALS AND METHODS 
Animal Models of Alcohol Feeding and Drug Administration 
          C57BL/6J, hif1α-fl/fl, and Villin-Cre mice were purchased from Jackson 
Laboratory (Bar Harbor, ME). IEhif1α-/- mice were generated by crossing hif1α-fl/fl 
and Villin-Cre mice as previous described [39]. The Cre mice were used as 
controls in this study (WT). Eight to ten-week old male mice (WT and IEhif1α-/-) 
were pair-fed a Lieber-DeCarli liquid diet containing alcohol (AF) or isocaloric 
maltose dextrin (PF). In the first week, all groups of mice were given modified 
Lieber-DeCarli liquid diet without alcohol to acclimate the mice to the liquid diet. 
Starting at week 2, alcohol was gradually introduced and increased to 5% (w/v) 
at the end of the week and was continued at 5% for 24 days. This modified 
Lieber-DeCarli diet contained 17% of energy as protein, 40% as fat, 7% as 
carbohydrate, and 35% as either alcohol (5% w/v) or isocaloric maltose dextrin 
(Research Diets, New Brunswick, NJ). A group of mice was treated with non-
absorbable antibiotics (Polymyxin B, 150 mg/kg BW/day and Neomycin, 200 
mg/kg BW/day) at day 12 of the 5% alcohol-feeding period. Control mice were 
gavaged daily with an equal volume of vehicle (water). Lactobacillus rhamnosus 
GG was supplemented to one group of mice at a dose of 109 CFU/day. A group 
of mice was administered 8 mg of dimethyloxalylglycine (DMOG, Cayman 
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Chemical, Ann Arbor, MI) intraperitoneally every other day for the last 2 weeks of 
ethanol diet feeding. Intestinal tissues of mice treated with alcohol using same 
protocol described above for 48 days (from another study) were used for HIF-1α 
analysis.  All animal protocols were approved by the Institutional Animal Care 
and Use Committee of the University of Louisville.  
 
Histological analysis 
          The liver and small intestine tissues were collected in 4% 
paraformaldehyde and then imbedded in paraffin. Tissues were cut into 5μm 
sections and stained with hematoxylin and eosin (H&E) and analyzed by light 
microscopy. For hepatic lipid accumulation analysis, frozen liver sections were 
stained with Oil Red O to visualize neutral lipids. Nuclei were counterstained with 
hematoxylin. Neutrophil accumulation in the livers was assessed by 
chloroacetate esterase (CAE) (Sigma, St. Louis, MO) staining. Intestine and liver 
macrophages were evaluated by F4/80 immunofluorescent staining.    
 
Tissue triglyceride  
          Liver tissues were homogenized in distilled water and the homogenate was 
collected for lipid extraction. Triglyceride content was determined using 
commercially available colorimetric kits (Thermo Scientific, Waltham, MA). 
 
Serum ALT assay 
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          Mouse serum was collected by orbital vein bleeding at time of euthanasia. 
Serum alanine aminotransferase (ALT) levels were analyzed by Piccolo Xpress 
system (ABAXIS, Union City, CA). 
 
Endotoxin assay  
          All material used for harvesting blood and measuring endotoxin was 
pyrogen free. An endpoint chromogenic Limulus amebocyte lysate (LAL) 
endotoxin kit was used to determine plasma LPS levels according to the 
manufacturer’s protocol (Lonza, Basel, Switzerland).  
 
Immunofluorescent staining of FFPE tissue.  
          Formalin-fixed paraffin embedded (FFPE) tissue was processed for 
staining as described previously with certain modifications [34]. Following 
deparaffinization, antigen retrieval was performed in unmasking solution (Vector 
Laboratories, Burlingame, CA) for 20 min at 125 oC in a Decloaking chamber 
(Biocare Medical, Pacheco, CA). Unreacted aldehydes were quenched for 10 
min with 1% NaBH4. Prior to blocking, ImageIT enhancer (Invitrogen, Carlsbad, 
CA) was applied to each section. Non-specific antibody binding was blocked with 
either 1% IgG-free BSA or 5% Normal donkey serum (Jackson Immuno, West 
Grove, PA) in TBS (Tris-buffered saline), depending on the antibodies used. 
Primary antibodies were incubated overnight at 4oC. Sections were washed with 
TBS, and AlexaFluor-conjugated secondary antibodies (Invitrogen) were applied 
for 30 min at room temperature. DAPI counterstain (Invitrogen) was used to 
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image nuclei and slides were mounted with ProLong gold (Invitrogen). Primary 
antibodies used were: E. coli (Abcam, Cambridge, MA), F4/80 (Abcam), Claudin-
1 (Santa Cruz, Dallas, TX), and Occludin (Santa Cruz). 
 
Quantitative PCR (qPCR) 
          Total RNA from liver and ileal tissues was isolated with TRIzol according to 
manufacturer's protocol (Invitrogen), and total RNA was reverse transcribed (RT) 
using Sensiscript Reverse Transcriptase and oligo(dT) (Applied Biosystems, 
Foster City, CA) to yield the cDNA. The cDNA was amplified in 96-well reaction 
plates with a SYBR green PCR Master Mix (Applied Biosystems) on an ABI 7500 
real-time PCR thermo cycler. The primers used in this study are listed in the 
Supplementary Table 1. Data were expressed as relative mRNA levels using the 












































Western blot analysis 
          Liver and ileal tissues were lysed on ice for 30 min in IPB (50 mM Tris·HCl, 
pH 7.4, 150 mM NaCl, 2 mM EDTA, 4 mM Na3VO4, 40 mM NaF, 1% Triton X-100, 
1 mM PMSF, 1% protease inhibitor cocktail) and centrifuged at 14,000 x g for 10 
min. The supernatants were collected. An appropriate amount of protein in total 
tissue lysates was resolved by SDS-polyacrylamide gel electrophoresis and 
transferred onto a polyvinylidene difluoride membrane (Whatman, Sanford, ME). 
Membranes were blocked for 1 h in Tris-buffered saline/Tween 20 (10 mM Tris–
HCl, pH 8.0, 150 mM NaCl, and 0.05% Tween 20) containing 5% nonfat dry milk 
and incubated overnight at 4°C with the different primary antibodies diluted in 
blocking buffer. Subsequently, membranes were incubated with peroxidase-
conjugated second antibodies. Following treatment with supersignal west HRP 
substrate (MilliporeSigma, Billerica, MA), protein bands were detected by a 




          Mouse fecal pellets were collected and processed as described previously 
[45]. Briefly, fecal pellets were suspended in PBS at a concentration of 1g 
feces/15 ml PBS and vortexed vigorously for 5 minutes. Serial dilutions of fecal 
homogenates were prepared in sterile Lysogeny Broth (LB) medium (BD 
Biosciences, San Jose, CA) in 15-ml tubes. The tubes were shaken for 24-48 h 
	 18		
at 37oC under aerobic conditions. Bacterial growth was monitored by measuring 
OD600. 
 
Statistical analysis  
Statistical analyses were performed using the statistical computer 
package, GraphPad Prism version 6, (GraphPad Software Inc., San Diego, CA, 
USA). Results are expressed as means ± SEM. Statistical comparisons were 
made using one-way analysis of variance (ANOVA) with Tukey’s post hoc test, or 
Student’s t-test where appropriate. Differences were considered to be significant 





IEhif1α-/- Mice Have Exacerbated Alcohol-Induced Hepatic Steatosis 
          To examine the role of the intestinal HIF-1α in experimental alcoholic liver 
disease, we generated intestinal epithelial specific knockout mice (IEhif1α-/-) by 
crossing hif-1αfl/fl mice with Villin-Cre mice. To confirm the deletion effectiveness, 
the chemical hypoxia inducer, CoCl2, was administered to mice via 
intraperitoneal injection, and liver and intestine HIF-1α protein was 
immunoblotted. CoCl2 induced a prominent increase in HIF-1α protein in the liver, 
but the changes were minimal in the intestine, indicating the effectiveness of the 
epithelial specific HIF-1α deletion (Fig.1). Chronic alcohol feeding for 24 days 
	 19		
increased hepatic micro- and macro-steatosis in both WT and IEhif1α-/- mice. 
This effect was more pronounced in IEhif1α-/- mice, as shown in Fig. 2A and 2B. 
Liver to body weight ratio was not changed in WT mice, but was significantly 
increased in IEhif1α-/- mice (Fig. 2C). Confirming the histological findings, liver 
triglyceride level was increased by alcohol feeding in WT mice (not statistically 
significant), but it was markedly increased in the IEhif1α-/- mice (Fig. 2D). Alcohol 
feeding significantly increased hepatic SREBP-1 mRNA level in both WT and 
IEhif1α-/- mice, but the effect was much greater in IEhif1α-/- mice compared to WT 
mice, indicating an increased lipogenesis in IEhif1α-/- mice exposed to alcohol 
(Fig. 2E). Fasting serum glucose level was slightly decreased by alcohol feeding. 
However, the KO mice had significantly higher glucose levels compared to WT 
mice fed alcohol (Fig. 3A). Serum triglyceride (Fig. 3B) and total cholesterol 
levels (Fig. 3C) in IEhif1α-/- mice were slightly lower under pair-fed conditions 
compared to WT mice. WT mice had decreased total cholesterol and triglyceride 
levels, which were significantly increased in IEhif1α-/- mice after alcohol feeding. 
Alcohol feeding did not affect serum levels of LDL (Fig. 3D) in either WT or 
IEhif1α-/- mice, but serum HDL (Fig. 3E) and VLDL levels (Fig. 3F) were 









Figure1. Expression of HIF-1α in different organs with or without the hypoxia 
inducer. CoCl2 (intraperitoneally injected with 60 mg/kg, mice were sacrificed at 
3h after CoCl2 injection) is used as a chemical hypoxia treatment, HIF-1α protein 
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Figure 2. Intestinal Hif1α KO (IEhif1α-/-) mice display exacerbated chronic 
alcoholic liver injury and steatosis. WT and IEhif1α-/- mice were fed pair-fed liquid 
diet (Lieber DeCarli) containing either 5% alcohol (alcohol-fed, AF) or isocaloric 
maltose–dextrin (pair-fed, PF) for 24 days. (A) Hematoxylin and eosin staining of 
the liver sections of PF and AF WT and IEhif1α-/- mice. Original magnification, 
×10.  (B) Oil red O staining of the liver neutral lipids of PF and AF WT and 
IEhif1α-/- mice. (C) Liver weight to body weight ratio of WT and IEhif1α-/- mice fed 
PF or AF diets. (D) Quantification of hepatic triglyceride content. (E) Gene 






























Figure 3. Effect of alcohol on lipid metabolism. Mice were fed alcohol-containing 
Lieber DeCarli diet for 24 days as described in the Material and Methods. The 
serum level of glucose (A), triglyceride (B), total cholesterol (C), low-density 
lipoprotein cholesterol (D), high-density lipoprotein cholesterol (E), and very low-
density lipoprotein cholesterol (F) were detected in WT (PF, AF) and the KO (PF, 
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Alcohol Increases Hepatic Inflammatory Response in IEhif1α-/- mice 
          Next, we analyzed alcohol exposure-induced inflammation in IEhif1α-/- mice. 
Alcohol feeding increased hepatic inflammation in IEhif1α-/- mice as evidenced by 
increased inflammatory foci (Fig. 2A arrows). As shown in Fig. 4A, IEhif1α-/- mice 
had an increased infiltration of cytotoxic neutrophils (CAE staining) in the liver 
compared to WT mice in response to alcohol feeding. Additionally, 
immunohistochemical staining using F4/80 revealed more inflammatory 
macrophages in the livers of IEhif1α-/- mice (Fig. 4B). More intense neutrophil 
infiltration and macrophage activation in livers of IEhif1α-/- mice were associated 
with elevated gene expression of the pro-inflammatory cytokines, tumor necrosis 
factor alpha (TNF-α) and IL-6, and the chemokine MCP-1 (Fig. 4C, 4D and 4E). 
Hepatic TLR4 protein level increased in IEhif1α-/- mice after alcohol exposure (Fig. 
5).  Serum levels of ALT were increased in both WT and IEhif1α-/- mice (Fig. 4F). 
Taken together, these results demonstrate that IEhif1α-/- mice have enhanced 






































































































































Figure 4. Inflammatory responses in EtOH-induced liver injury. (A) Chloroacetate 
esterase (CAE) localization (cell-localized fuchsia staining) in livers of WT and 
IEhif1α-/- mice fed PF and AF diets for 24 days. Original magnification, ×10. 
Arrows indicates neutrophil infiltration. (B) F4/80 staining of the liver tissues of PF 
and AF WT and IEhif1α-/- mice.  Arrows indicate positive staining. DAPI (blue) 
was used to counterstain nuclei. Original magnification, ×10.  (C, D, E) Hepatic 
gene expression of proinflammatory cytokines TNF-α, IL-6 and the chemokine 
MCP-1, respectively. (F) Serum alanine aminotransferase (ALT) activities of PF 




























Figure 5. Effect of alcohol on hepatic Toll-like receptor 4 protein expression.  
Mice were fed alcohol-containing Lieber DeCarli diet for 24 days as described in 
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Alcohol Increases Hepatic Fibrosis in IEhif1α-/- mice 
 
 Sirius Red staining of the liver sections showed a marginal increase of 
fibrosis in WT mice by alcohol feeding. IEhif1α-/- mice had a significant increase 
in Sirius Red positive area compared to WT mice (Fig. 6A). The gene expression 
of fibrogenic factors, collagen α1 and αSMA, were marginally increased in the 
WT mice, but significantly increased in IEhif1α-/- mice, by alcohol feeding (Fig. 6B 
and 6C). This suggests that intestinal epithelial HIF-1α depletion exacerbates 
































Figure 6: IEhif1α-/- mice have exacerbated liver fibrosis following alcohol 
treatment. (A) Sirius Red staining of the liver sections. The degree of fibrosis was 
evaluated by semi-quantification of Sirius Red positive area. (B) gene expression 


















































































IEhif1α-/- Mice Exhibit Gut Dysbiosis and Hepatic Bacterial Translocation  
          Previous studies showed that ALD is associated with gut dysbiosis and 
endotoxin release. We next determined whether gut bacterial homeostasis and 
the translocation of bacteria and bacterial products from the intestine into the 
circulation are affected by the absence of intestinal Hif1α. Fecal samples were 
analyzed by 16S ribosomal RNA bacterial primer sets to evaluate the effect of 
alcohol on bacterial overgrowth. As shown in Fig.7A, total bacterial load was 
unchanged in the WT mice, but significantly increased in the IEhif1α-/- mice after 
24 days of chronic alcohol feeding, indicating a bacterial overgrowth. 
Metagenomic analysis showed that alcohol feeding markedly increased phylum 
levels of Bacteroidetes and decreased Firmicutes in IEhif1α-/- mice (Fig. 7B). 
Further, 16S PCR analysis showed that Akkermansia spp. was increased in 
IEhif1α-/- mice but not in the WT mice (Fig. 7C). Interestingly, Lactobacillus spp. 
was decreased by alcohol in WT mice, and was almost undetectable in IEhif1α-/- 
mice (Fig. 7D). These data indicated that IEhif1α-/- mice had an exacerbated gut 
dysbiosis following 24-day alcohol exposure. Intestinal antimicrobial peptides, 
secreted by epithelial cells such as enterocytes, Goblet and Paneth cells, play a 
critical role in gut microbiota homeostasis.  Interestingly, alcohol exposure 
decreased the numbers of Goblet cells in the mucosal tissues of both WT and 
IEhif1α-/- mice, but the effect was exacerbated in IEhif1α-/- mice (Fig. 7E). β-
defensins are the dominant classes of antimicrobial peptide secreted by the 
epithelium. The gene expression of β-Defensin-1 and -2 was increased by 
alcohol exposure in the ileal tissue of WT mice, while it remained unchanged in 
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the IEhif1α-/- mice, following alcohol exposure (Fig. 7F and 7G). Cathelicidin 
related antimicrobial peptide (CRAMP) is the only member of cathelicidin anti-
microbial peptide family in mice. Alcohol exposure significantly reduced CRAMP 



















































































































































































Figure 7. Effect of Hif1α on alcohol-induced dysbiosis. (A) The total bacterial 
load in the cecum of PF and AF WT and IEhif1α-/- mice. (B) Phylum levels of 
microbiota in fecal samples of PF and AF WT and IEhif1α-/- mice. (C, D) 
Akkermansia (Verrucomicrobia phylum) and Lactobacillus (Firmicutes phylum) 
levels of PF and AF WT and IEhif1α-/- mice.  (E) Goblet cell staining and 
quantification of the ileal tissues of PF and AF WT and IEhif1α-/- mice. (F, G, H) 
β-Defensins (β-Defensins-1, 2) and cathelicidin-related antimicrobial peptide 
(CRAMP) gene expression in the ileal tissues of PF and AF WT and IEhif1α-/- 













































































Induction of HIF in the Intestinal Epithelial Cells Inhibits Mouse Fecal 
Bacterial Growth  
          The role of intestinal HIF-1α in gut lumen bacterial growth was further 
analyzed in an in vitro assay. T84 intestinal epithelial cells were incubated with 
DMOG (Dimethyloxaloylglycine), a HIF-1α activator.  The conditioned medium 
was added to the mouse fecal bacterial culture in LB media, and bacterial growth 
rate was determined. As shown in Fig. 8A, DMOG itself did not change the fecal 
bacterial growth over the period of 6 hours. However, DMOG-conditioned 
medium significantly inhibited bacterial growth at the 5- and 6-hour time points, 
indicating HIF-1α-mediated secreted factors from epithelial cells likely possess 
anti-microbial capacity. To further confirm whether HIF-1α activation can increase 
anti-microbial capabilities, we determined anti-microbial peptide expression in 
T84 cells after treatment with DMOG. The gene expression of human β-
Defensin-1, -2 (hBD-1, 2) and human cathelicidin related antimicrobial peptide 
(LL-37) was increased significantly by DMOG in T84 cells (Fig. 8B-D), indicating 


































Figure 8. Effect of HIF activation on the bacterial growth and antimicrobial 
peptide gene expression. (A) Mouse fecal bacterial growth in response to DMOG 
and DMOG-conditioned medium in T84 cells. (B, C, D) Gene expression of LL-37 



























































































HIF1α-deficiency Induces Intestinal Barrier Dysfunction After Chronic 
Alcohol Exposure   
          Increased bacterial translocation indicates intestinal barrier dysfunction. 
Immunofluorescent staining showed a decreased expression of the TJ proteins, 
occludin and claudin-1, in the ileal tissues of WT mice after alcohol exposure. 
Importantly, these decreases were more severe in IEhif1α-/- mice (Fig. 9A and 
9B). The decreased TJ protein expression was associated with the disruption of 
intestinal protective factors, such as ITF and P-gp. ITF plays an important role in 
intestinal mucus layer protection. Protein level of ITF was significantly lower in 
the IEhif1α-/- mice compared to the WT mice (Fig. 9C). Furthermore, P-gp (also 
known as multidrug resistance protein 1, MDR1) plays an important role in 
overall intestinal barrier integrity, and it was upregulated by alcohol in WT mice. 

































































































Figure 9. Effect of Hif-1α on intestinal barrier integrity. In (A, B) 
Immunoflorescent staining of occludin (green) and claudin-1 (blue) in the ileal 
tissues of PF and AF WT and IEhif1α-/- mice. DAPI (blue) was used to 
counterstain nuclei. Original magnification, ×10. (C) ITF protein Western blotting 
and quantification of ileal tissues of PF and AF WT and IEhif1α-/- mice 
normalized by β-actin. (D) P-gp gene expression in ileal tissues of PF and AF WT 
and IEhif1α-/- mice. *P<0.05, **P<0.01, ***P<0.001.  
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Alcohol Increases Intestinal Inflammatory Response in IEhif1α-/- Mice 
Histologic examination revealed a prominent inflammatory response in the 
ileum of IEhif1α-/- mice exposed to alcohol (Fig. 10A). Alcohol feeding significantly 
increased macrophage-like appearance in Peyer's patches (PPs), a major 
component of the gut-associated lymphoid tissue which serve as important 
antigen entry sites in mucosal immunity.  The PP domes were irregular, and the 
surrounding villi were sparse and atrophic (Fig. 10A), indicating an increased 
intestinal inflammatory response in the small intestines of IEhif1α-/- mice exposed 
to alcohol. We further analyzed alcohol-induced intestinal inflammation in the 
IEhif1α-/- mice. Immunofluorescent analysis revealed an increased number of 
cells expressing F4/80 in alcohol-treated-IEhif1α-/- mice compared with WT mice 
(Fig. 10B). Intestinal inflammation in the IEhif1α-/- mice by alcohol exposure was 
further confirmed by the increased mRNA levels of pro-inflammatory cytokines, 






































































































Figure 10. Effect of Hif-1α on intestinal inflammation. (A) HE staining of ileal 
tissues. Original magnification, ×10. PF-fed WT and IEhif1α-/- mice show normal 
architecture and rounder, light "hollows" (black arrows) in the epithelium 
representing the apical cytoplasm of the goblet cells, which is filled with mucin-
containing secretory vesicles. Abundant infiltrating cells showed a macrophage-
like appearance in Peyer's patches (PPs) (white arrows), Peyer's patches’ domes 
were irregular, and the surrounding villi were sparse and atrophic in ethanol-
treated IEhif1α-/- mice. (B) Immunofluorescent staining of F4/80 (red) showed 
increased macrophages in ileum of AF IEhif1α-/- mice (arrows). DAPI (blue) was 
used to visualize nuclei. Original magnification: ×10. (C, D, E) Ileum IL-6, IL-1β 
and TNF-α mRNA levels. *P<0.05.  
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Alcohol Increases Intestinal Permeability and Bacterial Translocation	
           Increased intestinal barrier damage and inflammation leads to higher 
intestinal permeability and induces greater bacteria translocation. To further 
determine the role of epithelial HIF-1α in alcohol-induced translocation of 
bacteria/bacterial products to the liver, we analyzed circulating LPS concentration 
and Escherichia coli (E. coli) protein in the liver. As shown in Fig.11A, serum LPS 
level was slightly elevated by alcohol feeding in the WT mice, but significantly 
increased in IEhif1α-/- mice. Furthermore, hepatic contents of E. coli protein were 
increased in WT mice following alcohol exposure, and this increase was more 
pronounced in IEhif1α-/- mice, as evaluated by immunofluorescent staining of 






















































Figure 11. Effect of Hif-1α on gut permeability and bacterial translocation. (A) 
Serum LPS levels. (B) Hepatic staining of E. coli protein (green staining, arrows,). 






















Antibiotic Sterilization of the Gut Reduces Alcohol-Induced Liver Fat 
Accumulation and Injury  
          To further elucidate the role of gut bacteria in alcohol-induced liver 
steatosis and injury in IEhif1α-/- mice, non-absorbable antibiotics (ABx; Polymyxin 
B and Neomycin) were administered to the mice exposed to alcohol for 12 days. 
ABx treatment decreased hepatic fat accumulation (Fig. 12A), liver triglyceride 
levels (Fig. 12B) and serum ALT levels (Fig. 12C) in both WT and IEhif1α-/- mice. 
However, these effects were more pronounced in IEhif1α-/- mice. These results 
support the concept that gut dysbiosis is critical in alcohol-induced hepatic 































Figure 12. Effects of non-absorbable broad-spectrum antibiotics (ABx) on EtOH-
induced liver steatosis and injury. WT and IEhif1α-/- mice were fed 5% alcohol 
liquid diets for 24 days. Antibiotics treatment was started at day 12 after alcohol 
feeding, and mice were gavaged daily until harvesting. (A) Oil red O staining of 
hepatic tissues. Original magnification, ×10. (B) Quantification of hepatic 






































HIF-1α is Required for the Protective Effect of Lactobacillus rhamnosus GG 
in ALD 
          Our previous studies have shown that the probiotic, LGG, protects against 
ALD by increasing intestinal HIF signaling and modifying gut bacterial 
homeostasis [38]. In this study, we tested whether HIF-1α is required for the 
protective effects of LGG. IEhif1α-/- and WT mice were fed 5% (w/v) alcohol for 
10 days and a single dose of alcohol was gavaged in the morning of last day, as 
described previously [37]. LGG was administered by gavage at a dose of 109 
CFU/day along with alcohol exposure. Agreeing with previous study, LGG 
administration significantly reduced hepatic fat accumulation resulting from 
alcohol exposure in WT mice. However, these protective effects were diminished 
in IEhif1α-/- mice, suggesting that HIF-1α is required for the beneficial effects of 



































Figure 13. Effects of Hif-1α on Lactobacillus rhamnosus GG treatment in ALD. (A) 
HE staining revealed LGG administration reduced steatosis by alcohol exposure 
in WT mice. However, LGG protective effects were diminished in IEhif1α-/- mice. 


























          The gut-liver axis plays an important role in the pathogenesis of chronic 
liver disease in experimental animals and humans. Intestinal dysbiosis and the 
disruption of the intestinal barrier integrity by alcohol are prominent features of 
ALD. Previous studies demonstrated that alcohol exposure-associated changes 
in gut metabolites and antimicrobial peptide production contribute to ALD [6, 9, 
18]. The mechanisms by which alcohol disrupts the antimicrobial peptide 
response leading to dysbiosis and intestinal barrier dysfunction are not fully 
understood. In this study, we investigated the role of intestinal HIF-1α in the gut-
liver axis in ALD using intestinal epithelial specific HIF-1α deficient mice. In 
IEhif1α-/- mice, 24-day alcohol exposure diminished the HIF-1α-mediated 
adaptive response on intestinal integrity and gut bacterial homeostasis, resulting 
in an exacerbated liver steatosis, inflammation, fibrosis and injury.  
          Pathogenic bacteria overgrowth and a reduction of beneficial bacteria 
constitute gut dysbiosis in ALD. The gut microbiota homeostasis is controlled by 
bacteria-bacteria and bacteria-host interactions under both healthy and diseased 
conditions. Alcohol exposure disrupts microbiota homeostasis. However, the gut 
mucosal response has adaptive mechanisms to restore homeostasis by 
increasing antimicrobial substances. We postulate that epithelial HIF-1α 
represents such an adaptive mechanism. We speculated that disruption of HIF-
1α signaling in the intestine would cause/exacerbate gut dysbiosis following 
alcohol exposure. Consistent with our previous research, 24-day alcohol 
exposure changed gut microbiota homeostasis slightly in WT mice. However, 
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depletion of intestinal epithelial HIF-1α resulted in a more severe dysbiosis.  The 
IEhif1α-/- mice had reduced Firmicutes and increased Bacteroidetes in their fecal 
samples. Such a change has been shown in a mouse model of ALD using 
intragastric feeding [40]. At the bacterial species level, Akkermansia (Akk), gram-
negative anaerobic bacteria, were not affected by alcohol in WT mice, but were 
increased in the IEhif1α-/- mice. The role of Akk in the ALD remains elusive. 
Supplementation with Akk showed a protective effect in ALD [41], while an 
endogenous increase of Akk may impact the intestinal innate immune system 
and facilitate bacterial translocation by degrading the intestinal mucus [42, 43]. 
The causal relation between an intestinal increase in Akk and intestinal integrity 
needs further study.  Interestingly, Lactobacillus bacteria were markedly depleted 
by 24-day alcohol exposure in WT mice, and this decrease was even more 
pronounced in IEhif1α-/- mice. A recent study demonstrated that Lactobacillus 
utilized saturated long-chain fatty acids, and these saturated fatty acids were 
beneficial in ALD treatment [44]. A short-chain fatty acid, butyrate, plays an 
essential role in epithelial cell nutrition and intestinal physiology. Butyrate 
regulates epigenetic processes through HDAC inhibition. Intestinal consumption 
of butyrate causes local hypoxia leading to increased HIF-1α expression. 
Although Lactobacillus itself does not produce butyrate, studies have shown that 
Lactobacillus promotes eubiosis, thereby resulting increased butyrate production. 
Butyrate-producing bacteria are mainly in the phylum Firmucutes, which was 
decreased by alcohol in our study. Furthermore, the decrease of Lactobacillus in 
ALD is consistent with the beneficial effect of LGG supplementation on ALD as 
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shown by several authors [37, 38, 45-47]. Taken together, our results 
demonstrate that depleting intestinal epithelial HIF-1α causes gut dysbiosis 
following a 24-day alcohol feeding regimen in mice.   
          HIF-1α is a master transcription factor regulating a variety of genes in the 
intestine. Anti-microbial peptides, β-defensin and CRAMP, are regulated by HIF-
1α [27, 30]. Paneth cell-derived β-defensins and epithelial cell- and microphage-
derived CRAMP regulate gut microbiota homeostasis. Our results showed that β-
defensins were adaptively increased and CRAMP was decreased by 24-day 
alcohol exposure in WT mice. However, depleting HIF-1α eliminated β-defensin 
upregulation and further decreased CRAMP. This, at least partially, explains why 
IEhif1α-/- mice developed dysbiosis following alcohol exposure. In contrast, 
activation of HIF-1α in epithelial T84 cells inhibited bacterial growth and 
increased antimicrobial gene expression. In vivo activation of HIF-1α by DMOG 
demonstrated a partial prevention of ALD. However, this observation is not 
conclusive because DOMG treatment is not intestine specific. While intestinal 
HIF-1α might be beneficial in ALD, hepatic activation of HIF-1α showed 
contradictory results [48, 49]. The causative role of gut dysbiosis in IEhif1α-/- mice 
in ALD was further demonstrated by sterilization of the gut using non-absorbable 
antibiotics. Treatment with ABx reduced ALD regardless the presence or 
absence of the HIF-1α gene in mice.  
          Previous studies in inflammatory bowel disease showed that intestinal HIF-
1α deficiency causes intestinal leakiness [28, 33]. The current study showed that 
IEhif1α-/- mice had an increase in intestinal permeability in ALD [9]. Subsequently, 
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bacteria and bacterial products translocated from the intestinal lumen to the 
systemic circulation and liver. As shown in our results, IEhif1α-/- mice displayed a 
higher LPS level in the serum and an increased E. coli protein in the liver after 
alcohol feeding. LPS binds to TLR4 on hepatocytes and Kupffer cells resulting in 
hepatic fat accumulation and inflammation in ALD, which is an established and 
well-studied mechanism in chronic ALD.  
          How does HIF-1α impact intestinal barrier function? In addition to the effect 
of HIF-1α on antimicrobial peptide regulation, HIF-1α also regulates several 
critical factors that are important in intestinal barrier integrity. P-gp functions as a 
pump by expelling translocated xenobiotics and bacterial toxins from the 
enterocytes into the intestinal lumen. ITF is a mucus modifier that helps to 
maintain a dynamic mucus layer. Claudin-1 is a major tight junction protein in the 
intestinal epithelial. Previous studies have demonstrated that these proteins are 
HIF-1α targets [19, 26, 28]. Reduction in ITF, claudin-1 and P-gp in IEhif1α-/- mice 
following alcohol exposure destabilizes gut barrier function resulting in elevated 
LPS concentration in serum and E. coli protein in the liver, as seen in our study. 
In addition, previous studies also showed that alcohol exposure increased 
intestinal Cyp2E1 expression [50], which is responsible for the production of ROS 
in the intestine. Furthermore, alcohol feeding significantly increased intestinal 
inflammation in IEhif1α-/- mice. Taken together, these multiple mechanisms 
contribute to the exacerbated gut barrier dysfunction in IEhif1α-/- mice in ALD.    
          Our previous studies have shown that long-term (8 weeks) alcohol 
exposure decreased HIF-2α protein levels in mouse intestine [37]. However, HIF-
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1α was not evaluated. Given the importance of HIF-1α in the regulation of 
intestinal homeostasis, we examined the expression of HIF-1α in this study. To 
our surprise, 24-day alcohol exposure increased HIF-1α mRNA expression in WT 
mice. However, a decreased HIF-1α expression in the ileum was observed after 
48 days alcohol exposure. The HIF-1α target genes, β-defensins, P-gp and ITF 
[19, 26, 30] , were also increased in the WT mice by 24 days alcohol exposure. 
          The increase in HIF-1α signaling resulting from the relatively short alcohol 
exposure (24 days) likely represents an adaptive upregulation during the initial 
period. However, this adaptive response is decreased with prolonged alcohol 
exposure. Depletion of intestinal HIF-1α gene diminished the upregulation of 
these antimicrobial peptides and barrier protective genes, suggesting a HIF-1α-
mediated transcriptional regulation.    
          Our previous studies demonstrate that the probiotic, LGG, is beneficial in 
preventing/treating of ALD in mice. However, the beneficial effects were 
diminished when HIF-1α was deleted in the intestine. LGG is able to increase the 
luminal concentrations of long-chain fatty acids and short-chain fatty acids in 
mice exposed to alcohol. Lactobacilli, in turn, metabolize saturated fatty acids to 
keep their growth. On the other hand, supplementation with tributyrin, a prodrug 
of butyrate, protects from intestinal tight junction disruption by alcohol [44]. 
Currently, it is still unclear as to how butyrate protects tight junctions, but other 
research showed that butyrate metabolism in in the intestine consumes oxygen 
and stabilizes HIF-1α [51], which is protective in the intestinal barrier. Thus, it is 
likely that LGG promotes butyrate-producing bacteria growth, and the resulting 
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butyrate production increases HIF-1α stabilization and protects the intestinal 
barrier. Intestinal HIF-1α depletion abolishes this protective effect of LGG against 
alcohol-induced intestinal barrier disruption.  
           In conclusion, our findings demonstrate that intestinal epithelial HIF-1α is 
critically involved in the intestinal pathogenesis of alcohol-induced barrier 
disruption and subsequent liver injury. HIF-1α activation regulates gut bacterial 
homeostasis though increasing anti-microbial peptides and stabilizes barrier 
function via upregulation of P-gp and tight junction proteins. The probiotic, LGG, 
exerts its beneficial effects through intestinal HIF-1α-mediated pathways in ALD. 
Dietary approaches and pharmacological agents that activate intestinal HIF-1α 















DSS-INDUCED INTESTINAL DAMAGE EXACERBATES LIVER INJURY 
 BY ACUTE ALCOHOL EXPOSURE IN MICE: ROLE OF INTESTINAL 





          An acute form of alcoholic liver disease (ALD), alcoholic hepatitis (AH) is a 
specific clinical syndrome characterized by hepatocellular necrosis, jaundice, an 
inflammatory reaction with numerous polymorphonuclear leukocytes and fibrosis 
in patients with a recent history of heavy alcohol consumption [1–3]. AH has 
been linked with excessive alcohol drinking over a prolonged period of time. 
However, it is now recognized that many patients diagnosed with AH report 
alcohol use over shorter periods of time before diagnosis.	 Binge drinking is 
defined by the National Institute on Alcohol Abuse and Alcoholism as the 
consumption of 5 or more drinks by a male or 4 or more drinks by a female in 
about 2 hours, resulting in a blood alcohol concentration of 0.08% or greater [4,5]. 
          The importance of the gut-liver axis is increasingly recognized in alcoholic 
liver disease and in decompensation in other chronic liver diseases [6–8]. Animal 
and human studies have shown that alcohol consumption causes “leaky gut,” 
translocation of bacteria and microbial compounds across the intestinal
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basement membrane into the portal and systemic circulation. Emerging evidence 
has revealed an acute dose of alcohol increases circulating markers of bacterial-
product translocation across the gut barrier even in healthy individuals[9].  
Circulating bacterial products such as lipopolysaccharide (LPS) are one of the 
hallmarks of ALD. They can activate Toll-like receptor 4 (TLR-4) signaling 
pathways and initiate an innate immune response[10]. However, the mechanisms 
for induction of inflammation in ALD have not been clarified completely. 
          Inflammatory bowel diseases (IBD), chronic intestinal inflammatory 
process, are characterized by repeated injury of the intestinal mucosa, loss of the 
intestinal epithelial barrier function and microvascular disturbance [11–13]. 
Exposure to DSS (dextran sulfate sodium) leads to increased intestinal 
permeability and mucosal changes in the ileum and colon in experimental 
animals [14,15]. This chronic colitis model results in increased portal LPS 
concentrations, which may be a clue to the development of ALD in patients with 
chronic or binge alcohol consumption. However, the involvement of alcohol 
consumption in IBD-associated ALD has not been explored in previous studies.  
          Observations from both humans and experimental animals suggest that 
colonic hypoxia is significantly increased to the gut following both alcohol 
exposure and colitis [16,17]. Interestingly, a number of barrier-protective and 
anti-microbial peptide genes are critically regulated by hypoxia-inducible factor-
1a (HIF-1a), including intestinal trefoil factor (ITF), claudin-1, multidrug 
resistance gene-1 (MDR1), b-Defensin-1 and CRAMP [18–22]. HIF-1α is 
expressed in inflamed mucosa from IBD patients and mouse models of colitis. 
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Studies of murine IBD have revealed that loss of epithelial HIF-1α correlates with 
more severe clinical symptoms, whereas constitutive activation of HIF-1 is 
protective [23].  Our previous studies also determined that intestinal epithelial 
specific HIF-1α knockout worsened alcohol-induced liver injury and resulted in a 
more severe dysbiosis. Despite this, the role of intestinal HIF-1α in IBD patients 
and an animal model of colitis with chronic and binge alcohol consumption has 
rarely been examined. According, the aim of this current study was to determine 
whether intestinal HIF1α deletion increases intestinal permeability resulting in an 
elevation of endotoxemia in a dextran sulfate sodium (DSS)-induced colitis 
murine model, and exacerbates acute alcohol-induced intestinal damage and 
liver injury.  
	
MATERIALS AND METHODS 
Animal Models of Dextran Sulfate Sodium and Alcohol Feeding  
 
C57BL/6J, hif1α-fl/fl, Villin-Cre and CAMP-/- mice were purchased from Jackson 
Laboratory (Bar Harbor, ME). IEhif1α-/- mice were generated by crossing hif1α-fl/fl 
and Villin-Cre mice as previous described.  Colitis was induced by feeding mice 3% 
DSS dissolved in drinking water for 7 days, and the mice were killed by 
decapitation on the seventh evening. Control mice received water without DSS. A 
model of binge alcohol was made by the treatment of mice with EtOH gavage at 
a dose of 6 g/kg body weight and the mice were killed 9 h after the administration. 
Control mice were gavaged with an iso-caloric amount of dextrose. The DSS plus 
alcohol model was produced in mice pre-treated DSS 7 days, then given EtOH 
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gavage at a dose of 6 g/kg. The mice were killed 9 h after the ethanol 
administration.  All animal protocols were approved by the Institutional Animal 
Care and Use Committee of the University of Louisville.  
 
Histological analysis 
The liver and small intestine tissues were collected in 4% paraformaldehyde 
and then imbedded in paraffin. Tissues were cut into 5μm sections and stained 
with hematoxylin and eosin (H&E) and analyzed by light microscopy. Apoptotic 
cell death in the liver and cell culture was assessed by detection of DNA 
fragmentation using an ApopTag peroxidase in situ apoptosis detection kit 
(Millipore, Billerica, MA). Goblet cells were stained with Alcian blue (Sigma, St. 
Louis, MO) and counterstained with Nuclear Fast Red. 
 
Tissue triglyceride  
Liver tissues were homogenized in distilled water and the homogenate was 
collected for lipid extraction. Triglyceride content was determined using 
commercially available colorimetric kits (Thermo Scientific, Waltham, MA). 
 
Serum ALT and AST assay 
Mouse serum was collected by orbital vein bleeding at time of euthanasia. Serum 
alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were 




IL-6 and TNF-α levels in serum were measured with ELISA assay kits (BD, 
Sparks, MD). Serum CRAMP level was measured by ELISA assay kit 
(Mybiosource, San Diego, CA). 
 
Endotoxin assay  
All material used for harvesting blood and measuring endotoxin was pyrogen free. 
An endpoint, chromogenic Limulus amebocyte lysate (LAL) endotoxin kit was 
used to determine plasma LPS levels according to the manufacturer’s protocol 
(Lonza, Basel, Switzerland).  
 
Immunofluorescent staining of FFPE tissue.  
Formalin-fixed paraffin embedded (FFPE) tissue was processed for staining as 
described previously with slight modification. Following deparaffinization, antigen 
retrieval was performed in unmasking solution (Vector Laboratories, Burlingame, 
CA) for 20 min at 125oC in a Decloaking chamber (Biocare Medical, Pacheco, 
CA). Unreacted aldehydes were quenched for 10 min with 1% NaBH4. Prior to 
blocking, ImageIT enhancer (Invitrogen, Carlsbad, CA) was applied to each 
section. Non-specific antibody binding was blocked with either 1% IgG-free BSA 
or 5% Normal donkey serum (Jackson Immuno, West Grove, PA) in TBS (Tris-
buffered saline), depending on the antibodies used. Primary antibodies were 
incubated overnight at 4oC. Sections were washed with TBS and AlexaFluor-
conjugated secondary antibodies (Invitrogen) were applied for 30 min at room 
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temperature. DAPI counterstain (Invitrogen) was used to image nuclei, and slides 
were mounted with ProLong gold (Invitrogen). Primary antibodies used were: 
TLR-4 (Abcam) and Claudin-1 (Santa Cruz, Dallas, TX). 
 
Western blot analysis 
Liver and ileal tissues were lysed on ice for 30 min in IPB (50 mM Tris·HCl, pH 
7.4, 150 mM NaCl, 2 mM EDTA, 4 mM Na3VO4, 40 mM NaF, 1% Triton X-100, 1 
mM PMSF, 1% protease inhibitor cocktail) and centrifuged at 14,000 x g for 10 
min. The supernatants were collected. An appropriate amount of protein in total 
tissue lysates was resolved by SDS-polyacrylamide gel electrophoresis and 
transferred onto a polyvinylidene difluoride membrane (Whatman, Sanford, ME). 
Membranes were blocked for 1 h in Tris-buffered saline/Tween 20 (10 mM Tris–
HCl, pH 8.0, 150 mM NaCl, and 0.05% Tween 20) containing 5% nonfat dry milk 
and incubated overnight at 4°C with the different primary antibodies diluted in 
blocking buffer. Subsequently, membranes were incubated with peroxidase-
conjugated second antibodies. Following treatment with supersignal west HRP 
substrate (MilliporeSigma, Billerica, MA), protein bands were detected by a 
ChemiDoc Molecular Imager (Bio-Rad, Hercules, CA). Data were normalized to 
b-actin.  
 
Quantification of GFP-E.coli translocation toward mesenteric adipose 
tissue to liver 
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Ampicillin-resistant GFP-E.coli were obtained from R ́emy Burcelin’s lab 
(Rangueil Hospital, Department of Therapeutics, Toulouse, France). Five hours 
after gavage with 109 GFP-E.coli, mice were sacrificed. Mesenteric adipose 
tissue (MAT) and liver were harvested. Tissues were then homogenized in Luria 
Broth (LB) (BD, Sparks, MD), plated onto ampicillin-supplemented (100mg/ml) 






Intestinal epithelial Hif1α-deficiency exacerbates DSS-induced colitis 
          First, the role of intestinal epithelial Hif1α in inflammatory bowel disease 
(IBD) was examined in DSS-induced colitis in IEHIF1α-/- mice. IEHIF1α-/- mice 
and the control mice were treated with DSS (3%) in drinking water for seven days. 
All of mice that received DSS developed typical clinical signs of colitis, including 
weight loss, diarrhea and rectal bleeding. As shown in Fig 1A, 7-day DSS 
treatment reduced body weight by about 10% in WT mice, but by nearly 30% in 
the IEHIF1α-/- mice. IEHIF1α-/- mice had a significant shorter colon compared to 
the control mice, which is a symptom of DSS-induced colitis in mice (Fig. 1B).  
Overall disease scores were higher in the IEHIF1α-/- mice than in the control mice 
(Fig 1C). As expected, DSS treatment significantly increased spleen size, 
indicating an increased systemic inflammation. However, there was no difference 
in spleen/body weight between control and IEHIF1α-/- mice (Fig. 1D). The 
liver/body weight ratio was not changed by DSS treatment in either control mice 
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or the IEHIF1α-/- mice (Fig. 1E). H&E staining of liver sections revealed normal 
liver histology in both control and the IEHIF1α-/- mice fed DSS (Fig. 1F). The 
hepatic triglyceride level and ALT, AST levels confirm the histological observation 
(Fig. 1G, H). These results indicate that DSS-induced acute colitis did not affect 
































































































































































































Figure 1. Effect of DSS on clinical symptoms and liver histopathological signs in 
a mouse colitis model. (A) Changes in body weights and (B) clinical scores of 
IEHIF1α-/-    mice and control mice administered 3% DSS; mice were monitored 
every day. Body weight values are expressed as a percentage of the starting 
body weight. (C) Colons were excised from mice and their lengths were 
measured 7 days after initiating DSS administration. Macroscopic features of the 
colons. (D, E) Liver/spleen weight to body weight ratio of WT and IEhif1α-/- mice 
fed water or DSS. (F) Hematoxylin and eosin staining of the liver sections of 
water and DSS WT and IEhif1α-/- mice. Original magnification, ×10. (G) Serum 
alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities 
of water and DSS WT and IEhif1α-/- mice.  *P<0.05, ***P<0.001. 
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Acute EtOH on DSS increases systemic inflammation 
          To evaluate the effect of acute alcohol exposure on animals with DSS-
induced colitis, we administered EtOH (6 g/kg) by oral gavage 9 hours before 
sacrifice on the last day. Acute alcohol did not affect body weight or colon length 
(Fig. 2A, B). However, alcohol on DSS treatment significantly increased 
spleen/body weight ratio in the IEHIF1α-/- mice compared to the WT mice (Fig. 
2C). In addition, alcohol on DSS increased serum TNF- α and IL-6 level in 
IEHIF1α-/- mice (Fig. 2D, E), suggesting that intestinal epithelial HIF-1α plays a 































































































































Figure 2. Inflammatory responses in binge EtOH on DSS-induced colitis. (A) 
Changes in body weights of IEHIF1α-/- mice and control mice administered 3% 
DSS plus one binge of 6 g/kg EtOH. (B) Colons were excised from mice and their 
lengths were measured 7 days after initiating 3% DSS with EtOH administration. 
(C) Spleen weight to body weight ratio of WT and IEhif1α-/- mice fed 3% DSS with 
binge EtOH. (D, E) Systemic expression of proinflammatory cytokines TNF-α and 
IL-6 in serum. *P<0.05, **P<0.01, ***P<0.001.   
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DSS-induced colitis enhances binge alcohol induced hepatic inflammation 
          Plasma ALT levels were significantly enhanced by acute alcohol 
administration in both WT and IEHIF1α-/- mice, while plasma AST showed a 
marginal increase (Fig. 3A and 3B). Interestingly, when the mice were pretreated 
with DSS, acute EtOH only marginally increased plasma ALT and AST levels in 
WT mice, while a significant increase in ALT and AST was observed in the 
IEHIF1α-/- mice (Fig. 3A and 3B). However, hepatic TG had only a trend of 
increase in both types of mice when the colitis mice were exposed to EtOH (Fig. 
3C). H&E staining of the liver sections showed an increase in steatosis in both 
types of mice, but the degree of steatosis was higher in the IEHIF1α-/- mice (Fig. 
3D).  
          Next, we measured hepatic apoptosis. TUNEL assay revealed that acute 
EtOH administration in DSS-primed mice significantly increased apoptotic cell 
death in both types of mice. However, the apoptotic cells were significantly 
greater in number in the IEHIF1α-/- mice compared to WT mice (Fig. 3E).  
          TLR4 mediates the inflammatory effects in the liver in response to 
endotoxin (LPS) derived from the gut lumen. Immunofluorescent staining of TLR4 
in liver tissues and hepatic TLR4 immunoblotting showed no differences among 
groups of WT mice and IEHIF1α-/- mice fed EtOH (Fig. 3F and 3G). However, 
alcohol on DSS significantly increased hepatic TLR4 expression in both types of 
mice. Comparing the WT mice and IEHIF1α-/- mice, we observed a significant 
increase in TLR4 protein level in the livers of IEHIF1α-/- mice (Fig. 3F and 3G).  
Taken together, the data presented above demonstrate that DSS pretreatment 
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primed mice for acute alcohol-induced liver injury; intestinal epithelial HIF-1α 











































































































































































Figure 3. IEhif1α-/- mice have exacerbated liver injury by alcohol on DSS 
treatment. (A, B) Serum alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) activities of WT and IEhif1α-/- mice.  Control group 
(without DSS; water), binge alcohol group (6 g/kg) and 3% DSS+ 6 g/kg EtOH 
administration group. (C) Quantification of hepatic triglyceride content. (D) 
Hematoxylin and eosin staining of the liver sections. Original magnification, ×10. 
(E) Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) 
assay in the liver section, quantitative measurements of TUNEL-positive cells in 
liver. Original magnification, ×10. (F) Immunoflorescent staining of Toll-like 
receptor 4 (TLR-4) in the liver section. DAPI (blue) was used to counterstain 
nuclei.  Original magnification, ×10. (G) TLR-4 protein Western blotting and 





IEHIF1α-/- mice exhibit enhanced plasma LPS levels and increased 
translocation of bacteria  
          Translocation of enteric bacteria and bacterial products into the liver plays 
an important role in acute alcoholic liver injury [25]. Treatment of EtOH or DSS 
alone in either WT mice or IEHIF1α-/- mice caused a marginal increase in plasma 
LPS concentration. However, EtOH on DSS treatment significantly increased 
plasma LPS levels in IEHIF1α-/- mice, but not in the control mice (Fig. 4A). To 
determine the live bacterial translocation, we gavaged mice with ampicillin 
resistant- and GFP-labeled E. coli and cultured mesenteric adipose tissue (MAT) 
and liver tissues. As shown in Fig 4B, live E. coli cells were identified in the liver 
of DSS-primed control mice treated with acute alcohol. Interestingly, the livers of 
IEHIF1α-/- mice had significantly increased numbers of E. coli cells, indicating 
depletion of intestinal HIF-1α enhanced bacterial translocation to the liver. As 
expected, MAT showed a significant numbers of live E. coli upon EtOH treatment 
in DSS-primed mice. However, there was no difference between WT mice and 
the IEHIF1α-/- mice (Fig 4B, and 4C). Taken together, our data demonstrate that 
in the DSS-primed mouse model, acute alcohol enhances the translocation of 
bacteria and bacterial products from the intestine lumen to extraenteric tissues 



















Figure 4. Effect of Hif-1α on gut permeability and bacterial translocation. (A) 
Serum LPS levels. (B) Macroscopic features of the GFP- E. Coli on the LB agar 
by UV light exposure. (C) Numbers of GFP-E. coli CFU/g of MAT and liver in 
IEhif1α-/-  mice and their corresponding WT controls treated 3% DSS+ 6 g/kg 



































Effect of DSS pretreatment on acute EtOH induced intestinal barrier 
dysfunction and CRAMP depletion shows exacerbated liver injury 
          Goblet cells play a critical role in antimicrobial peptide production and 
barrier function. Alcian blue staining of colon tissues showed that EtOH on DSS 
treatment significantly decreased goblet cells in WT mice, and this depletion was 
more pronounced in IEHIF1α-/- mice (Fig.5A). The histological analysis of the 
distal colon revealed marked mucosal damage, characterized by an intense 
inflammatory cell infiltrate extending throughout the mucosa and submucosa, and 
crypt destruction in IEHIF1α-/- mice (Fig. 5A). To further define the role of Hif1α in 
mediating intestinal barrier dysfunction after alcohol administration, we analyzed 
expression of claudin-1, one of the tight junction (TJ) proteins in the epithelial 
tissues, and the antimicrobial peptide, CRAMP.	 Immunofluorescence staining of 
claudin-1 revealed that IEHIF1α-/- mice showed a lower expression in the ileum 
after DSS plus ethanol feeding (Fig. 5B). DSS induced a marked increase in 
CRAMP expression in WT mice. However, this elevation was impaired in the 
IEHIF1α-/- mice (Fig. 5C). When the DSS-pretreated mice were exposed to EtOH, 
CRAMP expression was significantly decreased in WT mice, and the decrease 
was more pronounced in the IEHIF1α-/- mice (Fig. 5C). Circulating CRAMP was 
increased by DSS pretreatment in WT mice, but not in IEHIF1α-/- mice. 
Interestingly, EtOH exposure eliminated the increased CRAMP produced by DSS 
in the WT mice (Fig. 5D).  Next, we examined the liver injury by EtOH in DSS-
pretreated CRAMP knockout mice.  Acute EtOH on DSS pretreatment 
significantly increased plasma ALT and AST levels in WT mice, and more so in 
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Figure 5. Effect of DSS pretreatment on acute EtOH induced intestinal barrier 
dysfunction. (A) Alcian blue staining of representative sections from the proximal 
colon of WT and IEhif1α-/- mice treated with 3% DSS plus 6 g/kg EtOH. 
Quantification of the number of Alcian blue–positive goblet cells per crypt-villus 
unit was performed. (B) Immunoflorescent staining of Claudin-1 in the colon 
section. DAPI (blue) was used to counterstain nuclei.  (C) CRAMP protein 
Western blotting and quantification of colon tissues normalized by β-actin. (D) 
Serum level of CRAMP was measured by ELISA kit. (E) Serum alanine 
aminotransferase (ALT) and aspartate aminotransferase (AST) activities of WT 







          The association between colitis and liver disease was first described in the 
late 19th century [26,27]. Emerging evidence shows alcohol and high fat diet are 
increasingly being recognized as a cause of hepatic steatosis among patients 
with IBD[28–31]. Although there are few clinical reports about ALD with IBD 
patients, there is no study showing that ulcerative colitis with alcohol exposure 
enhances liver injury and liver failure. In this study, we first describe a link 
between the colonic inflammatory response and alcohol induced hepatic injury. 
          In the present study, data obtained showed that in intestinal HIF-1a KO 
mice, DSS exposure induced clinical symptoms, systemic inflammatory reaction 
and colonic inflammation characterized by increased local pro-inflammatory 
mediators and histopathological changes. These observations are similar to 
those described in either epithelial HIF-1a−/− mice or HIF-1β−/−mice[32,33]. 
However, liver injury was not observed in DSS-colitis either WT or KO mice, and 
there were no histopathological changes or up regulation of inflammatory 
mediators. These results suggest a limited involvement of the liver in the colitis 
process, which is in agreement with previous animal and human studies[34–37]. 
Among these studies, one explained this phenomenon is DSS-induced 
experimental colitis leads to endotoxin tolerance for liver, but did not provide 
more mechanisms.  
          The main question in our study was whether colitis can enhance alcohol 
induced liver injury. Although liver injury was not observed in DSS-colitis mice, 
we considered that the portal endotoxemia (in colitis model) facilitated the liver 
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injury induced by other compounds, because small amounts of LPS are known to 
enhance susceptibility to various hepatotoxic agents [38]. A recent study showed 
that the systemic biologic activity of the increased LPS after alcohol binge 
contributed to the increased inflammatory cytokines in liver[9]. In the present 
study, contrary to expectation, we observed no change of ALT and AST in the 
acute alcohol on DSS-colitis mice compared to ALT and AST in mice exposed 
only to an alcohol binge, indicating that exposure of a single alcohol binge 
impairs liver to the same extent as does the DSS and alcohol treatment. 
However, the most surprising finding is that serum ALT and AST levels 
significantly increased in HIF-1a−/− mice after a single binge alcohol on colitis and 
this liver injury was confirmed by elevated levels of hepatic pro-inflammatory 
mediators and histopathological changes. 
          Intestinal HIF-1a plays an important role in the colitis model because a 
number of barrier-protective genes are critically regulated by HIF-1α, including 
intestinal trefoil factor (ITF), CD73, P-glycoprotein (P-gp), cathelicidin (CRAMP), 
and claudin-1,muc3 and β-defensin1 (DEFB1) [19–23]. Based on this, we 
considered that intestinal HIF-1α deletion might exacerbate gut-permeability and 
dampen the intestinal innate immunity response; binge alcohol as the second hit 
induced more inflammation and greater gut permeability in colitis mice. Among 
these finding, one of the most important results is that the expression of the 
antimicrobial peptide, CRAMP, was significantly increased in both colon and 
serum, illustrating the attempt to re-establish the disturbed barrier. However, we 
did not find the same results in alcohol treatment and in the HIF-1a KO mice. 
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According to these results and in light of earlier findings, which demonstrated that 
alcohol has the potential to modulate intestinal CRAMP production. Recent 
studies have shown that a few antimicrobial peptides (AMPs) also have the 
potential to neutralize LPS-induced endotoxic effects.  Among these AMPs, the 
list included human LL-37 (mouse CRAMP) [39–41].  Although strong binding of 
CRAMP to LPS is not sufficient to block LPS biological activity, binding of 
CRAMP to LPS aggregates accompanied by aggregate dissociation prevents 
LPS from binding to the carrier protein LBP, or alternatively to its receptor, and 
hence inhibits cytokine release. Indeed, we showed that CRAMP reduced the 
level of mRNA expression of the two cytokines which stimulate by LPS in 
RAW264.7 cells. Therefore, we used global CRAMP knockout mice to investigate 
our hypothesis.  As we expected, binge alcohol on colitis enhanced liver injury in 
CRAMP KO mice compared with WT mice. All these results show that the 
intestinal HIF-1a - CRAMP pathway plays an important role in intestinal damage 
induced by alcohol-induced liver injury.    
           In summary, we provide new evidence that a concomitant colonic damage 
enhances hepatic injury in experimental ALD. Interestingly, the compensatory 
upregulation of antimicrobial peptides in mice with colitis was not significantly 
expressed in HIF-1a KO mice, and alcohol also further reduced its expression.  
This may facilitate gut-driveled LPS, bacteria and cytokine translocation, as 
evidenced by increased serum concentration.  To our knowledge, this is the first 
report which provides conclusive evidence that binge alcohol is a ‘‘second’’ hit, 
which is sufficient to induce hepatic inflammation in colitis without intestinal 
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CRAMP expression, regulated by HIF-1a gene expression. Our findings may 
also provide another mechanism for DSS induced endotoxin tolerance in the liver. 
Further studies are necessary to discover the mechanism of decreased intestinal 
antimicrobial peptide generation and precisely to determine the CRAMP-bind 
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